These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 21900420
1. Human papillomavirus type-specific risk of cervical cancer in a population with high human immunodeficiency virus prevalence: case-control study. Naucler P, Mabota da Costa F, da Costa JL, Ljungberg O, Bugalho A, Dillner J. J Gen Virol; 2011 Dec; 92(Pt 12):2784-2791. PubMed ID: 21900420 [Abstract] [Full Text] [Related]
2. Prevalence and correlates of cervical HPV infection in a clinic-based sample of HIV-positive Hispanic women. Ortiz AP, Tamayo V, Scorsone A, Soto-Salgado M, Febo I, Piovanetti P, Venegas-Ríos HL, Yamamura Y, Zorrilla C. Papillomavirus Res; 2017 Dec; 4():39-44. PubMed ID: 29179868 [Abstract] [Full Text] [Related]
3. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa. ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Chang-Claude J, Mtiro H, Mhina M, Kashaija P, Ockert S, Yu X. Int J Cancer; 1992 Jun 19; 51(4):515-21. PubMed ID: 1318265 [Abstract] [Full Text] [Related]
4. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control. Ndizeye Z, Vanden Broeck D, Lebelo RL, Bogers J, Benoy I, Van Geertruyden JP. PLoS One; 2019 Jun 19; 14(6):e0209303. PubMed ID: 31237894 [Abstract] [Full Text] [Related]
9. A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil. Castilho JL, Levi JE, Luz PM, Cambou MC, Vanni T, de Andrade A, Derrico M, Veloso VG, Grinsztejn B, Friedman RK. BMC Cancer; 2015 Jun 23; 15():478. PubMed ID: 26100400 [Abstract] [Full Text] [Related]
10. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. Blossom DB, Beigi RH, Farrell JJ, Mackay W, Qadadri B, Brown DR, Rwambuya S, Walker CJ, Kambugu FS, Abdul-Karim FW, Whalen CC, Salata RA. J Med Virol; 2007 Jun 23; 79(6):758-65. PubMed ID: 17457908 [Abstract] [Full Text] [Related]
11. Association of infections with human immunodeficiency virus and human papillomavirus in Honduras. Ferrera A, Melchers WJ, Velema JP, Figueroa M. Am J Trop Med Hyg; 1997 Aug 23; 57(2):138-41. PubMed ID: 9288804 [Abstract] [Full Text] [Related]
12. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection. van Aardt MC, Dreyer G, Pienaar HF, Karlsen F, Hovland S, Richter KL, Becker P. Int J Gynecol Cancer; 2015 Jun 23; 25(5):919-25. PubMed ID: 25950128 [Abstract] [Full Text] [Related]
13. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study. Dartell M, Rasch V, Kahesa C, Mwaiselage J, Ngoma T, Junge J, Gernow A, Ejlersen SF, Munk C, Iftner T, Kjaer SK. Sex Transm Dis; 2012 Mar 23; 39(3):201-8. PubMed ID: 22337107 [Abstract] [Full Text] [Related]
16. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women. Fakhry C, D'souza G, Sugar E, Weber K, Goshu E, Minkoff H, Wright R, Seaberg E, Gillison M. J Clin Microbiol; 2006 Dec 23; 44(12):4479-85. PubMed ID: 17021055 [Abstract] [Full Text] [Related]
20. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. Wallin KL, Wiklund F, Angström T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J. N Engl J Med; 1999 Nov 25; 341(22):1633-8. PubMed ID: 10572150 [Abstract] [Full Text] [Related] Page: [Next] [New Search]